Your browser doesn't support javascript.
loading
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models.
Sugawara, Tatsuo; Baumgart, Simon J; Nevedomskaya, Ekaterina; Reichert, Kristin; Steuber, Holger; Lejeune, Pascale; Mumberg, Dominik; Haendler, Bernard.
Afiliação
  • Sugawara T; Oncology II, Preclinical Research, Research and Development, Pharmaceuticals, Bayer AG, Berlin, Germany.
  • Baumgart SJ; Oncology II, Preclinical Research, Research and Development, Pharmaceuticals, Bayer AG, Berlin, Germany.
  • Nevedomskaya E; Oncology II, Preclinical Research, Research and Development, Pharmaceuticals, Bayer AG, Berlin, Germany.
  • Reichert K; Oncology II, Preclinical Research, Research and Development, Pharmaceuticals, Bayer AG, Berlin, Germany.
  • Steuber H; Structural Biology, Lead Discovery Berlin, Small Molecule Innovation, Research and Development, Pharmaceuticals, Bayer AG, Berlin, Germany.
  • Lejeune P; Oncology II, Preclinical Research, Research and Development, Pharmaceuticals, Bayer AG, Berlin, Germany.
  • Mumberg D; Oncology II, Preclinical Research, Research and Development, Pharmaceuticals, Bayer AG, Berlin, Germany.
  • Haendler B; Oncology II, Preclinical Research, Research and Development, Pharmaceuticals, Bayer AG, Berlin, Germany.
Int J Cancer ; 145(5): 1382-1394, 2019 09 01.
Article em En | MEDLINE | ID: mdl-30828788

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Receptores Androgênicos / Antagonistas de Receptores de Andrógenos / Neoplasias de Próstata Resistentes à Castração Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Receptores Androgênicos / Antagonistas de Receptores de Andrógenos / Neoplasias de Próstata Resistentes à Castração Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article